How Much Does A Procrit Injection Cost? | Real-World Pricing

Sticker prices swing based on dose strength, where it’s given, and who pays the bill. Below you’ll find typical cash ranges from pharmacy tools and price guides, how clinics bill for administration, what Medicare and commercial plans usually do, and lower-cost options that many patients use.

Procrit Injection Cost Breakdown And Typical Ranges

Retail cash quotes vary by strength. Pharmacies usually stock single-use preservative-free vials in multiple unit concentrations. The table below summarizes common doses and where those numbers show up in practice.

Dose Strength	Typical Cash Price (USD)	Where You’ll See It
2,000–10,000 units/mL	$55–$200 per mL	Small strength vials at retail; quoted on price guides and international price checks
20,000 units/mL (1 mL)	$500–$600 per mL	U.S. retail listings and price guides for single vials
40,000 units/mL (1 mL)	$1,050–$1,300 per mL	GoodRx/SingleCare cash quotes; common dose for adult titration
Clinic administration fee	$25–$150+	Infusion centers, oncology/renal clinics; billed as an injection or administration code

Why the spread? List prices on pharmacy discount tools set the tone, but local contracts, wholesaler markups, and shipping constraints can nudge numbers up or down. Clinic charges add an administration line even when the drug itself is supplied through the pharmacy benefit.

What Drives Your Out-Of-Pocket Number

Dose And Frequency

Dosing depends on indication, weight, hemoglobin trends, and response. Many adults start with a 40,000-unit weekly plan for chemotherapy-associated anemia, while chronic kidney disease dosing can differ and may shift after a few checks. More units per month raise the total quickly, even when the per-mL price stays the same.

Where The Injection Happens

There are two common paths:

• Buy-and-bill at a clinic. The facility purchases the vial and bills drug + administration. Your plan might apply coinsurance to a medical claim.
• Pharmacy fill + nurse visit. You pick up the vial at a retail or specialty pharmacy (pharmacy benefit), then pay a smaller visit fee for the injection. Some patients self-inject at home if cleared by the prescriber.

Insurance Benefit Type

Coverage can route through a medical benefit or a pharmacy benefit. Medical benefit claims often apply coinsurance after deductibles. Pharmacy benefit claims apply copays or tiered coinsurance and may require a biosimilar first.

Manufacturer And Biosimilar Choice

Clinically, biosimilars are designed to match efficacy and safety. Payers often nudge toward a lower-net-cost option. For epoetin products, the common biosimilar is epoetin alfa-epbx, sold as Retacrit. Cash quotes for that product tend to come in lower than the reference brand, which can shrink monthly expenses without changing the therapeutic class.

What Medicare Usually Does

Coverage depends on setting:

• End-stage renal disease on dialysis. Erythropoiesis-stimulating agents given in the dialysis facility are bundled into the dialysis payment, not paid separately under Part B. That means there’s no separate pharmacy copay for the vial; your responsibility is tied to the dialysis bundle rules.
• Non-dialysis settings. When used for covered indications in clinics, the drug is generally billed to Part B with coinsurance after deductible. Plans may have local coverage rules on starting hemoglobin, dose adjustments, and documentation.

You can read the Centers for Medicare & Medicaid Services policy language on erythropoiesis-stimulating agents in the official coverage database; the dialysis bundling rule for ESAs is spelled out there. We link to that section here: ESA billing under the ESRD bundle.

Safety, Monitoring, And Why It Matters For Cost

Keeping hemoglobin in the target range can lower dose needs over time. Going higher than the recommended range is linked to thrombotic events and other risks, so prescribers titrate carefully and may pause therapy when levels rise. The U.S. Food and Drug Administration keeps a safety page that summarizes boxed warnings and monitoring guidance: see the FDA’s information for epoetin alfa. Staying within the plan’s criteria and lab windows also helps prevent denied claims, which can otherwise bounce costs back to the patient.

Cash Quotes From Public Tools

For a single 40,000-unit vial at retail, public pharmacy tools often show starting prices just above $1,000. Single-dose 20,000-unit vials list near the mid-$500s. Third-party coupon platforms sometimes shave a few percent off those numbers, and specialty pharmacies may have their own schedules for clinic shipments.

These are snapshots, not contracts. They shift with wholesaler inventory and local markups. Always check your exact pharmacy and zip code to avoid surprises at pickup.

Head-To-Head Price Snapshot

Here’s a quick view of typical cash quotes by product family. Your plan may steer to one option, but the therapeutic goal is the same class effect: stimulate red blood cell production when indicated.

Product	Typical Cash Quote Per Dose	Notes
Procrit (epoetin alfa)	$1,000–$1,300 for 40,000 units	Retail tools often start near ~$1,050; clinic pricing varies by contract
Retacrit (epoetin alfa-epbx)	$500–$700 for comparable dose	Biosimilar; many plans prefer it and set lower copays
Aranesp (darbepoetin alfa)	$700–$900 for labeled dose	Different molecule; longer dosing intervals in many regimens

Realistic Scenarios And What People Pay

Self-Pay At Retail

A patient receiving 40,000 units weekly with a retail pickup could see $1,000–$1,300 per vial, or roughly $4,000–$5,200 across a four-week month. Using a pharmacy coupon sometimes trims the per-vial price by 5–15%. Biosimilar substitution can cut hundreds more.

Commercial Insurance, Medical Benefit

If the clinic buys the drug and bills under a medical claim, plans often apply 10–30% coinsurance after deductibles have been met. On a $1,100 acquisition cost, a 20% coinsurance is $220 per dose. Prior authorization is common; dose and hemoglobin targets must match the policy.

Medicare Beneficiary In A Dialysis Facility

The ESA is part of the dialysis payment formula. You won’t see a separate vial copay, though you may have cost share on the overall dialysis bundle per your plan and supplemental coverage.

Ways To Lower The Bill

Ask About The Biosimilar

If your prescriber is comfortable with epoetin alfa-epbx, plans often place it on a friendlier tier. Clinics with standing orders may already favor it; if not, asking can open a lower-cost route without changing the class.

Line Up The Right Benefit

When coverage sits on the pharmacy side, a prior authorization can approve more than one fill at a time, which reduces back-and-forth and avoids gaps. If the plan covers it under the medical side at the clinic, ask whether a specialty pharmacy shipment is allowed; some benefit designs lower out-of-pocket that way.

Use Real-Time Pharmacy Quotes

Call two or three pharmacies in your area for the same NDC and dose. Discount tools are a helpful compass, but local quotes win. If the difference is large, ask your prescriber to send the prescription to the lower quote.

Time Refills Around Labs

Because dose changes with hemoglobin results, lining up refills after the next lab can avoid paying for a higher strength than you’ll need. If your dose drops, the next vial might be a lower unit strength at a lower price.

What To Expect At The Clinic

When a clinic gives the shot, two lines commonly appear on the bill:

• The drug. Coded with a J-code or Q-code that maps to units administered.
• Administration. A small procedure code for the injection. This can be rolled into a visit, or listed as its own line if no separate visit occurred.

If you’re supplying the vial from a pharmacy, the clinic typically bills only the administration line. Keep the vial boxed and chilled per the label, and bring it in a cooler pack as instructed by the clinic.

Label Basics That Affect Use

Prescribers aim for hemoglobin targets that reduce transfusion needs without overshooting. The class carries boxed warnings about higher cardiovascular events when levels run high. That’s one reason dose changes can be frequent early on and why plans require recent lab values for approval. The FDA safety brief linked above recaps these points and is a reliable reference for patients who like to read official materials.

Sample Monthly Budgeting

Let’s say a patient needs four weekly doses around 40,000 units each:

• Retail self-pay: $4,000–$5,200 for the vials, plus any clinic injection fees if not self-administered.
• Commercial plan medical claim: If the clinic’s allowed amount is $1,100 per dose and coinsurance is 20%, expect about $880 paid by the plan and $220 by the patient per dose, after deductible. Four doses come to ~$880 out-of-pocket that month.
• Pharmacy benefit with biosimilar: Some plans set a flat copay in the low hundreds per fill; others use tiered coinsurance. When Retacrit is preferred, total monthly out-of-pocket often lands below the brand route.

When Prices Look Out Of Line

If your quote lands well above the ranges here, ask whether the NDC or strength differs from what the plan prefers. Specialty pharmacies sometimes have lower net prices to the plan, which reduces coinsurance. If the pharmacy can’t source a single-use vial at the listed strength, the nearest alternative may cost more per unit.

What To Ask Your Care Team

• Which strength and frequency match my current labs?
• Can we use the biosimilar that my plan prefers?
• Does my coverage route through the clinic or the pharmacy?
• What administration fees should I expect if I bring the vial?
• Can you send the script to the pharmacy with the best quote near me?

Bottom Line On Pricing

Most U.S. cash quotes cluster a little above $1,000 per 40,000-unit vial, with lower figures for smaller strengths and with biosimilar substitution. Insurance design and where the injection occurs shape the final number you pay. Matching dose to current labs, asking about the biosimilar, and confirming the correct benefit route go a long way toward keeping costs steady.

Editorial process: Price ranges in this guide reflect recent public pharmacy tools and coverage documents. Safety and coverage links point to primary sources. Always confirm your personal quote and benefits, since local contracts and policy updates can shift costs.